Skip to main content
. 2005 May 31;92(11):1976–1983. doi: 10.1038/sj.bjc.6602572

Table 5. Dose intensity of chemotherapy agents received according to fluoropyrimidine and dose.

    % of chemotherapy received
  No. of pts 5FU/capecitabine (%) Epirubicin (%) Platinum agent (%)
5FU 200 mg m−2 104 85.2 90.3 90.6
Capecitabine 500 mg m−2 b.i.d.−1 59 87.2 88.9 87.8
Capecitabine 625 mg m−2 b.i.d.−1 35 81.8 88.8 86.4

Pts=patients; ECF=epirubicin, cisplatin, 5-fluorouracil (5FU); ECX=epirubicin, cisplatin, capecitabine; EOF=epirubicin, oxaliplatin, 5-fluorouracil; EOX=epirubicin, oxaliplatin, capecitabine.

HHS Vulnerability Disclosure